Other OTC - Delayed Quote USD

Innovation Pharmaceuticals Inc. (IPIX)

0.0025 -0.0010 (-28.57%)
At close: 3:55 PM EDT
Currency in USD All numbers in thousands
Download
Breakdown
TTM
6/30/2023
6/30/2022
6/30/2021
6/30/2020
Total Revenue
--
--
18.0000
--
423.0000
Operating Expense
2,359.0000
2,939.0000
6,776.0000
9,015.0000
5,058.0000
Operating Income
-2,359.0000
-2,939.0000
-6,758.0000
-9,015.0000
-4,635.0000
Net Non Operating Interest Income Expense
-56.0000
-57.0000
-115.0000
-4,857.0000
-260.0000
Other Income Expense
-205.0000
-172.0000
-168.0000
--
-1,753.0000
Pretax Income
-2,620.0000
-3,168.0000
-7,041.0000
-13,872.0000
-6,648.0000
Net Income Common Stockholders
-2,620.0000
-3,168.0000
-7,041.0000
-13,872.0000
-6,648.0000
Diluted NI Available to Com Stockholders
-2,620.0000
-3,168.0000
-7,041.0000
-13,872.0000
-6,648.0000
Basic EPS
-0.01
-0.01
-0.01
-0.04
-0.03
Diluted EPS
-0.01
-0.01
-0.01
-0.04
-0.03
Basic Average Shares
509,363.4070
505,767.5990
503,867.1360
386,163.2080
238,436.3720
Diluted Average Shares
509,363.4070
505,767.5990
503,867.1360
386,163.2080
238,436.3720
Total Operating Income as Reported
-2,564.0000
-3,111.0000
-6,921.0000
-9,015.0000
-4,635.0000
Rent Expense Supplemental
47.0000
41.0000
74.0000
100.0000
133.0000
Total Expenses
2,359.0000
2,939.0000
6,776.0000
9,015.0000
5,058.0000
Net Income from Continuing & Discontinued Operation
-2,620.0000
-3,168.0000
-7,041.0000
-13,872.0000
-6,648.0000
Normalized Income
-2,620.0000
-3,168.0000
-6,900.0000
-13,872.0000
-4,793.0000
Interest Expense
56.0000
57.0000
115.0000
4,857.0000
260.0000
Net Interest Income
-56.0000
-57.0000
-115.0000
-4,857.0000
-260.0000
EBIT
-2,564.0000
-3,111.0000
-6,926.0000
-9,015.0000
-6,388.0000
EBITDA
-2,190.0000
-2,738.0000
-6,544.0000
-8,637.0000
-6,015.0000
Reconciled Depreciation
374.0000
373.0000
382.0000
378.0000
373.0000
Net Income from Continuing Operation Net Minority Interest
-2,620.0000
-3,168.0000
-7,041.0000
-13,872.0000
-6,648.0000
Total Unusual Items Excluding Goodwill
--
--
-141.0000
--
-1,855.0000
Total Unusual Items
--
--
-141.0000
--
-1,855.0000
Normalized EBITDA
-2,190.0000
-2,738.0000
-6,403.0000
-8,637.0000
-4,160.0000
6/30/2020 - 5/4/2007

Upgrade to begin using 40 years of financial statements and get so much more.

Perform in-depth fundamental analysis with decades of income statements, balance sheets, and cash flows — all exportable.

Upgrade

Related Tickers

NNVC NanoViricides, Inc.
1.1500
+0.88%
 
IGXT IntelGenx Technologies Corp.
0.1500
-8.48%
 
IGX.TO IntelGenx Technologies Corp.
0.2000
0.00%
 
MYMD MyMD Pharmaceuticals, Inc.
2.8600
+11.72%
 
MOR.DE MorphoSys AG
67.70
-0.07%
 
WXXWY WuXi Biologics (Cayman) Inc.
3.2500
-0.91%
 
CGEN Compugen Ltd.
1.9100
-3.54%
 
ACOGF Alpha Cognition Inc.
0.4928
-0.44%
 
SYBX Synlogic, Inc.
1.8700
-2.09%
 
ATHXQ Athersys, Inc.
0.0045
-2.17%